Bayer Visual Acuity Changes Grade 0

Known as: Grade 0 
No findings, no reporting from the patient.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2017
051019782017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND In our previous report, 3 of 10 patients with spinal cord injury who were injected with autologous mesenchymal stem… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2016
2016
BACKGROUND & AIMS Various grades of adverse events are associated with sorafenib and have recently been considered as a surrogate… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
IMPORTANCE Patient perspective on chemotherapy-related adverse effects is being increasingly acknowledged both in experimental… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2007
2007
BACKGROUND There are limited data on the impact of successful chronic total occlusion (CTO) revascularization by percutaneous… (More)
Is this relevant?
2006
2006
OBJECTIVE To evaluate the effectiveness and limitations of antegrade sclerotherapy (AS) for the treatment of primary varicocele… (More)
Is this relevant?
2003
2003
This retrospective study of impairments in a decentralized and integrated, routine Hansen's disease (HD) programme was done on a… (More)
Is this relevant?
1997
1997
A 13-year-old girl underwent a right salpingo-o-ophorectomy and partial omentectomy for an ovarian tumor that on microscopic… (More)
Is this relevant?
1996
1996
OBJECTIVE The purpose of our study was to evaluate the effectiveness of nitinol stents for palliation of dysphagia due… (More)
Is this relevant?
1990
1990
Sleep screening was used to discover the incidence of sleep apnoea in 50 children undergoing routine adenotonsillectomy for… (More)
Is this relevant?
1990
1990
Seventy-four children aged 0.3 to 21.4 years (median 4.0) were followed echocardiographically on days 4, 7, 14 and 28 (+/- 2 days… (More)
Is this relevant?